The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 08, 2019
Filed:
Dec. 19, 2016
Applicant:
Tris Pharma, Inc., Monmouth Junction, NJ (US);
Inventors:
Ketan Mehta, Cranbury, NJ (US);
Yu-Hsing Tu, West Windsor, NJ (US);
Assignee:
Tris Pharma, Inc., Monmouth Junction, NJ (US);
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 9/16 (2006.01); A61K 31/137 (2006.01); A61K 31/155 (2006.01); A61K 31/192 (2006.01); A61K 31/216 (2006.01); A61K 31/485 (2006.01); A61K 47/14 (2017.01); A61K 47/32 (2006.01); A61K 9/00 (2006.01); A61K 9/50 (2006.01); A61K 47/58 (2017.01); A61K 9/10 (2006.01); A61K 9/20 (2006.01); A61K 31/135 (2006.01); A61K 31/4458 (2006.01); A61K 9/14 (2006.01); A61K 31/4402 (2006.01); A61K 31/24 (2006.01); A61K 9/48 (2006.01); A61K 47/69 (2017.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 47/585 (2017.08); A61K 9/0053 (2013.01); A61K 9/0056 (2013.01); A61K 9/0095 (2013.01); A61K 9/10 (2013.01); A61K 9/14 (2013.01); A61K 9/167 (2013.01); A61K 9/1635 (2013.01); A61K 9/1664 (2013.01); A61K 9/2013 (2013.01); A61K 9/2027 (2013.01); A61K 9/2031 (2013.01); A61K 9/2077 (2013.01); A61K 9/2081 (2013.01); A61K 9/4866 (2013.01); A61K 9/5021 (2013.01); A61K 9/5026 (2013.01); A61K 31/135 (2013.01); A61K 31/137 (2013.01); A61K 31/155 (2013.01); A61K 31/192 (2013.01); A61K 31/216 (2013.01); A61K 31/24 (2013.01); A61K 31/4402 (2013.01); A61K 31/4458 (2013.01); A61K 31/485 (2013.01); A61K 45/06 (2013.01); A61K 47/14 (2013.01); A61K 47/32 (2013.01); A61K 47/6921 (2017.08); A61K 47/6927 (2017.08); A61K 47/6933 (2017.08);
Abstract
An aqueous liquid suspension containing a coated drug-ion exchange resin complex comprising a core composed of an amphetamine complexed with a pharmaceutically acceptable ion-exchange resin and an uncoated amphetamine-ion exchange resin complex is provided. The coated amphetamine-ion exchange resin complex is in admixture with a polymer to form a matrix. Methods of making the coated complex and the liquid suspension are described.